RXRX icon

Recursion Pharmaceuticals
RXRX

Overview Fund Activity

312 hedge funds and large institutions have $2.06B invested in Recursion Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 84 funds opening new positions, 114 increasing their positions, 60 reducing their positions, and 33 closing their positions.

Holders
312
Holders Change
+48
Holders Change %
+18.18%
% of All Funds
4.16%
Holding in Top 10
10
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+66.67%
% of All Funds
0.13%
New
84
Increased
114
Reduced
60
Closed
33
Calls
$30.7M
Puts
$30.9M
Net Calls
-$211K
Net Calls Change
+$8.19M

Top Buyers

1
SoftBank Group
1
SoftBank Group
Japan
$99.2M
2
NHAS
2
Novo Holdings A/S
Denmark
$68.4M
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$230M
4
BlackRock
4
BlackRock
New York
$158M
5
Citadel Advisors
5
Citadel Advisors
Florida
$18.5M

Top Sellers

1
RCM
1
RA Capital Management
Massachusetts
$52.2M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$47.8M
3
Voloridge Investment Management
3
Voloridge Investment Management
Florida
$0
4
Sumitomo Mitsui Trust Group
4
Sumitomo Mitsui Trust Group
Japan
$60.7M
5
NAMA
5
Nikko Asset Management Americas
New York
$60.1M
Name Holding Trade Value Shares
Change 		Shares
Change %
DM
26
Deerfield Management
New York
$15.6M – – –
Charles Schwab
27
Charles Schwab
California
$15.4M +$2.25M +333,323 +17%
UBS AM
28
UBS AM
Illinois
$15.3M +$801K +118,428 +6%
Goldman Sachs
29
Goldman Sachs
New York
$14M +$3.55M +525,504 +34%
Dimensional Fund Advisors
30
Dimensional Fund Advisors
Texas
$11.5M -$65.8K -9,739 -0.6%
Susquehanna International Group
31
Susquehanna International Group
Pennsylvania
$11.3M +$4.04M +597,390 +56%
Two Sigma Investments
32
Two Sigma Investments
New York
$11.2M +$427K +63,211 +4%
Nuveen Asset Management
33
Nuveen Asset Management
Illinois
$7.23M -$364K -53,835 -5%
JPMorgan Chase & Co
34
JPMorgan Chase & Co
New York
$7.15M -$805K -119,024 -10%
CFM
35
Comprehensive Financial Management
California
$6.37M – – –
VAS
36
Vestmark Advisory Solutions
Massachusetts
$6.36M +$844K +112,221 +15%
LIP
37
Liontrust Investment Partners
United Kingdom
$6.3M -$394K -58,273 -6%
Bank of America
38
Bank of America
North Carolina
$5.97M -$1.91M -282,561 -24%
Bank of New York Mellon
39
Bank of New York Mellon
New York
$5.75M -$510K -75,482 -8%
PIM
40
Platinum Investment Management
Australia
$4.96M +$3.7M +546,929 +294%
WP
41
Woodline Partners
California
$4.54M -$3.06K -452 -0.1%
NFGH
42
Nan Fung Group Holdings
Hong Kong
$4.49M +$4.49M +664,610 New
Barclays
43
Barclays
United Kingdom
$4.28M -$435K -64,307 -9%
PBPIA
44
Pivotal bioVenture Partners Investment Advisor
California
$4.03M +$4.03M +595,518 New
Rafferty Asset Management
45
Rafferty Asset Management
New York
$4.03M -$543K -80,319 -12%
IFWM
46
Institute for Wealth Management
Colorado
$3.93M +$3.93M +580,997 New
Lazard Asset Management
47
Lazard Asset Management
New York
$3.76M -$584K -86,458 -13%
Citigroup
48
Citigroup
New York
$3.39M +$2.1M +310,236 +163%
Swiss National Bank
49
Swiss National Bank
Switzerland
$3.29M +$876K +129,600 +36%
Wells Fargo
50
Wells Fargo
California
$3.1M +$2.32M +343,304 +298%
1
2
3 4 5